CEO SUMMARY: Congress may soon vote on a new bill that permanently reduces the amount of price cuts to Medicare Part B lab test prices, as specified under the Protecting Access to Medicare Act of 2014 (PAMA). The Saving Access to Laboratory Services Act (SALSA) eliminates a 15% payment cut for hundreds of lab tests […]
PAMA Cuts Might Be Reduced to Zero for 2023
New legislation aims to overhaul how Medicare calculates the Clinical Laboratory Fee Schedule
- By Scott Wallask
- > From the Volume XXIX, No. 11 - August 8, 2022 Issue
- Tags: acla, American Clinical Laboratory Association, Centers for Medicare and Medicaid Services, clfs, Clinical Laboratory Fee Schedule, CMS, CRD Associates, Erin Will Morton, HHS, LAB Act, lab risk & compliance, Maximal Brewer Selection, Medicare Part B, Medicare Payment Advisory Commission, MedPAC, national independent laboratory association, NILA, PAMA, Protecting Access to Medicare Act of 2014, SALSA, Saving Access to Laboratory Services Act, SGR, Sustainable Growth Rate, U.S. Department of Health and Human Services
